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Abstract
Evidence for serotonin involvement in impulsivity has generated interest
in the measurement of impulsivity in regular ecstasy users, who are
thought to display serotonergic dysfunction. However, current findings are
inconsistent. Here, we used a recently developed Information Sampling
Test to measure ‘reflection’ impulsivity in 46 current ecstasy users,
14 subjects who used ecstasy in the past, 15 current cannabis users and
19 drug-naïve controls. Despite elevated scores on the Impulsivity
subscale of the Eysenck Impulsiveness-Venturesomeness-Empathy
questionnaire, the current and previous ecstasy users did not differ
significantly from the drug-naive controls on the Information Sampling
Test. In contrast, the cannabis users sampled significantly less information
on the task, and tolerated a lower level of certainty in their decision-
making, in comparison to the drug-naive controls. The effect in cannabis
users extends our earlier observations in amphetamine- and opiate-
dependent individuals (Clark, et al., 2006, Biological Psychiatry 60:
515–522), and suggests that reduced reflection may be a common
cognitive style across regular users of a variety of substances. However,
the lack of effects in the two ecstasy groups suggests that the relationship
between serotonin function, ecstasy use and impulsivity is more complex.
Key words
addiction; cannabis; decision-making; inhibition; MDMA
Introduction
Impaired inhibitory control in drug addiction is thought to
underlie a breakdown of self-regulation that causes individuals
to continue drug administration, despite growing awareness of
the associated negative consequences (Goldstein and Volkow,
2002; Jentsch and Taylor, 1999; Lyvers, 2000). Inhibitory pro-
cesses can be quantified with neurocognitive measures of
impulsivity, where deficient performance has been demon-
strated in regular users of a wide range of substances, including
stimulants, opiates and alcohol (Bjork, et al., 2004; Fillmore
and Rush, 2002; Forman, et al., 2004). Impulsivity has received
particular attention in relation to the regular use of
3,4-methylenedioxymethamphetamine (MDMA) or ‘ecstasy’.
Studies of experimental animals have shown that MDMA has
selective neurotoxic effects on serotonin (5-hydroxytryptamine,
5-HT) neurons (Gouzoulis-Mayfrank and Daumann, 2006),
and this serotonin neurotoxicity may cause or exacerbate
impulsivity in human users. There is a longstanding association
between reduced serotonin neurotransmission and behavioural
impulsivity (Evenden, 1999b; Soubrié, 1986), derived from
behavioural pharmacology studies in experimental animals
(Tye, et al., 1977) and data associating serotonin metabolite
and precursor reductions with clinical impulse control disorders
(LeMarquand, et al., 1999; Linnoila, et al., 1983). Consistent
with these data, regular ecstasy users were reported to display
impulsive responding on several laboratory tests, including the
Matching Familiar Figures Test (MFFT) (Morgan, 1998; Mor-
gan, et al., 2002; Morgan, et al., 2006; Quednow, et al., 2007),
the Go/No Go test (Moeller, et al., 2002b) and the Stroop test
(Halpern, et al., 2004), in comparison to drug-naïve and
polydrug-using control groups.
However, the link between impulsivity and ecstasy use
remains problematic. Several case–control designs in MDMA
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sures [Go/No Go (Fox, et al., 2002; Gouzoulis-Mayfrank,
et al., 2003), Stop Signal Test (von Geusau, et al., 2004), Stroop
test (Dafters, 2006)]. Where positive results have been reported,
these effects may be limited to subsets of ecstasy users [heavy
users (Halpern, et al., 2004; Moeller, et al., 2002b), males (von
Geusau, et al., 2004)] or have not reached statistically signifi-
cance at conventional thresholds (Quednow, et al., 2007). In
addition, the positive results to date have widely assumed that
the impulsivity emerged as a consequence of ecstasy use via sero-
tonergic neurotoxicity, but have not satisfactorily excluded the
possibility that impulsivity pre-dates drug-taking, associated
with vulnerability mechanisms (Lyvers, 2006). At a conceptual
level, the 5-HT theory of impulsivity may represent an
over-simplification given evidence from experimental animals
that impulsive responses are negatively related to 5-HT levels
in subcortical regions, but positively related to 5-HT efflux in
the prefrontal cortex (Dalley, et al., 2002). These effects may
cancel out following global serotonergic depletion in humans,
and we previously reported no effects of dietary tryptophan
depletion on response inhibition in healthy volunteers (Clark,
et al., 2005).
A further problem lies in the measurement of impulsivity,
which is increasingly viewed as a multi-factorial construct
(Evenden, 1999b; Reynolds, et al., 2006). Substance abuse
may be differentially associated with various components of
impulsivity. Self-report impulsivity on questionnaire measures
is elevated in substance users of various drugs (Moeller, et al.,
2002a; Sher and Trull, 1994). These groups are also impaired
on different laboratory tests of impulsivity, including delay dis-
counting and response inhibition (Bickel and Marsch, 2001;
Bjork, et al., 2004; Fillmore and Rush, 2002). In the delay dis-
counting paradigm, impulsivity is defined as preference for
immediate small rewards over larger delayed rewards. On
tests of response inhibition, impulsivity is defined as a failure
to suppress automatic or dominant responses. It is striking that
whilst drug users display impairments on each of these mea-
sures, these different aspects of impulsivity are typically only
weakly correlated with one another (Dom, et al., 2007;
Reynolds, et al., 2006).
The present report focussed on a further aspect of impulsiv-
ity, which has received less attention in the context of drug use.
‘Reflection’ impulsivity refers to the tendency to gather and
evaluate information prior to decision-making, where impulsiv-
ity is associated with a failure of reflective processing. The con-
struct has typically been measured in children using the MFFT
(Kagan, 1966), where the subject is presented with a template
picture (e.g. a bicycle) and six similar variants. One variant is
identical to the template, and must be identified on each trial.
Impulsivity is indicated by rapid, inaccurate decisions. Two
experiments in ecstasy users by Morgan (1998) reported
reduced MFFT accuracy without significant effects on MFFT
latency. However, the MFFT places high demands on visual
search, visual working memory and strategy use, and these
domains may be independently disrupted in recreational
ecstasy users (Fox, et al., 2002), perhaps leading to inflated
error rates (see Block, et al. (1974) and Clark, et al. (2006)
for further critique of the MFFT).
In the present study, we have used an alternative measure of
reflection impulsivity that was designed to circumvent several
limitations of the MFFT. In the Information Sampling Test
(IST), the subject is presented with a 5 × 5 matrix that conceals
boxes that are each one of two colours (e.g. red or blue). The
subject must decide which of the two colours lies in the major-
ity under the matrix, by uncovering boxes one at a time. Once
uncovered, boxes remain visible for the remainder of the trial
such that the working memory load is negligible. As well as
reducing visual search and working memory demand, the IST
also enables the extraction of a direct measure of information
sampling (the probability of being correct at the point of deci-
sion) rather than a speed-accuracy composite as in the MFFT.
Critically, the extent of information sampling on the task is
closely correlated with the number of incorrect judgments,
meeting a core criterion for a test of reflection impulsivity
(Evenden, 1999a). We have also shown previously that infor-
mation sampling on the IST was associated with slow, accurate
responding on the MFFT, providing evidence for concurrent
validity (Clark, et al., 2003). Recently, we reported reduced
information sampling in chronic amphetamine and opiate
users (Clark, et al., 2006). Whilst healthy controls responded
at 81% certainty (95% confidence intervals: 77–85%) when
there was no cost to sampling information, current and former
users of amphetamines or opiates tolerated significantly lower
levels of certainty in their decision-making (Clark, et al., 2006).
The present study aimed to extend these data by examining
current and former ecstasy users, as well as drug-naïve con-
trols, and a fourth group of regular cannabis users who did
not report ecstasy use, as an active control group. We hypoth-
esized that information sampling would be reduced in the
cannabis users, and that this impulsivity would be further exac-
erbated in the current and former ecstasy users as a result of
serotonin neurotoxicity.
Materials and methods
Subjects
Participants were 46 current ecstasy users, 14 former ecstasy
users, 15 current cannabis users and 19 drug-naïve controls,
who were recruited from newspaper and magazine advertise-
ments in the Cambridge area. All ecstasy users reported a mini-
mum of 30 separate uses of the drug. Current users reported
abstinence for at least 3 weeks to allow for short-term recovery
of serotonin function, and the Ex-ecstasy users reported absti-
nence for at least 1 year. No participant tested positive for recent
stimulant use, as assessed by a blood screen. Demographic char-
acteristics are displayed in Table 1. All participants completed
the National Adult Reading Test (NART) (Nelson and Willi-
son, 1991) as an estimate of verbal IQ, the Beck Depression
Inventory to record abnormal mood symptoms and the Eysenck
Impulsiveness-Venturesomeness-Empathy (IVE) questionnaire
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ity. The protocol was approved by the Cambridge Local
Research Ethics Committee (LREC number 02/076) and all
volunteers provided written informed consent prior to
participation.
The information sampling task
The task was administered on a touch-sensitive 10.5 inch mon-
itor. Subjects completed a single practice trial, followed by 10
trials in each of two conditions: the Fixed Reward (FR) condi-
tion and the Reward Conflict (RC) condition. Condition order
was counter-balanced across subjects. On each trial, subjects
were presented with a 5 × 5 matrix of grey boxes, with two
larger coloured panels at the foot of the screen. Touching a
grey box caused the box to open (immediately) to reveal one
of the two colours at the foot of the screen. The subject was
asked to decide which colour was in the majority of the 25
boxes. They were told ‘It is entirely up to you how many
boxes you open before making your decision’ [for complete
instructions, see Clark, et al. (2006)]. To indicate their decision,
the subject touched the corresponding panel at the foot of the
screen, whereupon the remaining boxes were uncovered and a
feedback message ‘Correct! You have won [x] points’ or
‘Wrong! You have lost 100 points’ was presented immediately,
for 2 seconds. In the FR condition, the subject was awarded
100 points for a correct response, irrespective of the number
of boxes opened. In the RC condition, 250 points were avail-
able to win at the start of the trial, which decreased by 10
points with each box opened, thereby creating a conflict
between the level of certainty and the reward available. Incor-
rect responses yielded 100 points deduction in either condition.
In both conditions, the inter-trial interval (ITI) was of variable
delay (minimum 1s) such that the minimum interval between
trial onsets was 30 s (e.g. if the trial was completed in 20 s,
the ITI was 10 s). This feature was inserted to counteract
impulsive behaviour due to delay aversion.
Performance was indexed by the average number of boxes
opened, but in addition, the probability of making a correct
choice at the point of decision was calculated on each trial
[P(Correct); see Clark, et al. (2006) for formula]. Whilst these
two variables are typically correlated with one another, under
some circumstances the number of boxes opened can be a
limited index of the information available; for example,
20 boxes may be distributed 10:10 [P(Correct) = 0.50] or 15:5
[P(Correct) = 1.0]. Consequently, the P(Correct) variable is
related more directly to the levels of certainty tolerated during
decision-making, and was therefore the primary variable for
analysis. The number of errors was also recorded to test the
impact of reduced information sampling on decision-making
accuracy.
Statistical analysis
Data were analysed with SPSS (SPSS Inc, Chicago, Illinois,
USA) version 14 using two-tailed parametric tests thresholded
at P < 0.05. Demographic and questionnaire data were ana-
lysed using one-way ANOVA and chi-squared tests as appro-
priate. Thedrugandalcoholuse datawereanalysedwith one-way
ANOVA where normality assumptions were met, but in the most
part, were not normally distributed and were analysed with
nonparametric tests (Mann–Whitney and Kruskal–Wallis tests).
IST performance was analysed using mixed-model ANOVA.
Significant ANOVA group differences were decomposed using
Tukey’s post hoc tests, or Tamhane’s T2 where variances were
unequal.
Results
Demographic and drug use characteristics
The four groups did not differ significantly in NART-estimated
verbal IQ (F3,90 = 1.49, P = 0.224), but the gender ratio dif-
fered significantly across groups (χ2 = 8.81, P = 0.031) (see
Table 1). The ANOVA for group differences in ageapproached
significance (F3,90 = 2.36, P = 0.077), due to slightly older age
in the Ex-ecstasy group, although no post hoc tests were
significant. There was a significant group difference in BDI
score (F3,90 = 5.59, P = 0.001), due to elevated self-reported
Table 1 Demographic and personality variables of the four groups
Drug-naïve Ecstasy Ex-ecstasy Cannabis
N 19 46 14 15
Age 24.0 (3.6) 24.2 (6.7) 27.9 (6.6) 22.3 (4.3)
Gender (M:F) 12:7 33:13 6:8 5:10
Verbal IQ 114.6 (4.6) 110.4 (7.6) 110.3 (8.8) 111.3 (9.5)
BDI 3.5 (2.3) 9.3 (7.6)a 11.6 (9.2)a 5.3 (3.9)
IVE–Imp 6.8 (3.9) 10.6 (4.2)a 11.9 (5.1)a 8.9 (4.2)
IVE–Vent 10.4 (3.2) 11.0 (3.0) 9.4 (3.9) 10.9 (3.8)
IVE–Emp 12.0 (2.7) 12.7 (2.8) 14.5 (3.6) 13.7 (2.9)
M:F, male:female; BDI, Beck Depression Inventory; IVE, Eysenck Impulsiveness (Imp)-Venturesomeness (Vent)-Empathy (Emp) Questionnaire.
aP < 0.05 vs. Drug-naïve controls.
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drug-naïve controls (Tamhane’sT 2 ,P <0 . 0 0 0 1 a n d P =0 . 0 3 8
respectively). Neither BDI score nor age was significantly cor-
related with IST performance (r94 = 0.013 and r94 =0 . 1 7 7
respectively), so these variables were not considered as covariates.
There was a significant group difference in self-reported impulsiv-
ity on the Eysenck IVE (F3,90 =5 . 0 3 ,P = 0.003) due to elevated
scores in the Current ecstasy and Ex-ecstasy groups in compari-
son to drug-naïve controls (Tukey’s, P = 0.007 and P =0 . 0 0 6
respectively); the cannabis group did not differ from drug-naïve
controls (P = 0.469). There were no group differences on the Ven-
turesomeness (F3,90 =0 . 8 6 6 ,P = 0.462) or Empathy (F3,90 =2 . 4 6 ,
P = 0.067) subscales.
Drug and alcohol use data are displayed in Table 2. All sub-
jects consumed alcohol, although consumption (units/month)
differed significantly (F3,90 = 5.8, P = 0.001) with the Current
ecstasy group consuming more than that of the drug-naïve con-
trols and cannabis users (Tamhane’s T2; P < 0.0001 and
P = 0.001 respectively). All subjects in the three drug groups
smoked cigarettes, with no differences in monthly consumption
(F2,72 = 1.7, P = 0.191). The Current ecstasy and Ex-ecstasy
groups were comparable in terms of lifetime ecstasy exposure
(Mann–Whitney test; Z = 0.52, P = 0.606) and highest regular
dosage (Z = 1.2, P = 0.219), but the Current ecstasy group
reported higher peak single dose intake (i.e. the maximum
number of tablets consumed on a single occasion) (Z = 2.6,
P = 0.009), whereas the Ex-ecstasy group reported greater
maximum frequency of usage per month (Z = 2.3, P = 0.019).
As expected, the Ex-ecstasy group also had a longer abstinence
period (Z = 5.6, P < 0.001). The cannabis users reported simi-
lar current cannabis usage (joints per month) to the two ecstasy
groups (Kruskal–Wallis χ2 = 4.5, P = 0.106), although the two
ecstasy groups reported more total lifetime usage of cannabis
(χ2 = 6.1, P = 0.047). Subjects in the two ecstasy groups were
more likely than the cannabis group to have ever used psilocy-
bin (Fisher’s Exact χ2 = 19.1, P < 0.0001), LSD (χ2 = 16.2,
P < 0.0001), amphetamine (χ2 = 21.2, P < 0.0001), amyl nitrate
(χ2 = 21.8, P < 0.0001), ketamine (χ2 = 18.6, P < 0.0001),
cocaine (χ2 = 17.9, P < 0.0001) and opiates (χ2 = 12.4,
P = 0.001); although, there was modest usage of most of these
substances in the cannabis group.
IST performance
A mixed-model ANOVA of P(Correct) data (the probability of
being correct at the point of decision), with Condition (Fixed
Reward, Reward Conflict) as a within-subjects variable and
Group and Gender as between-subjects variables, revealed a
Table 2 Self-reported drug and alcohol use in the four groups [mean (SD)]
Drug-naïve Ecstasy Ex-ecstasy Cannabis
Alcohol (N) 1 9 4 61 41 5
Units last month 32.5 (28.1) 101.8 (99.5) 43 (66.8) 34.6 (25.1)
Tobacco (N) 0 46 14 15
Cigarettes last month – 172.4 (191.5) 238.8 (239.3) 107.0 (140.9)
Cannabis (N) 9 46 14 15
Life joints 7.1 (4.5) 6707.7 (9244.1) 10 379.2 (18 546.5) 2704.2 (6221.4)
Joints last month – 53.1 (80.9) 52.1 (121.9) 31.3 (53.7)
Ecstasy (N) 0 46 14 0
Life tablets – 609.1 (703.2) 1000.8 (1792.4) –
Peak intake (single dose) – 8.9 (4.5) 5.3 (2.8) –
Highest regular dose (tablets) – 4.7 (2.5) 4.0 (2.8) –
Highest regular frequency (times/month) – 5.7 (3.8) 11.2 (8.0) –
Time since last taken (days) – 71.9 (66.0) 1059.4 (1105.8) –
Psilocybin (N) 0 38 10 3
Times in lifetime – 14.1 (20.5) 14.3 (23.4) 3.5 (2.2)
LSD (N) 0 31 11 2
Trips in lifetime – 69.7 (165.2) 52.6 (115.3) 3.0 (1.4)
Amphetamine (N) 0 40 13 4
Grams in lifetime – 401.8 (1361.3) 268.6 (371.8) 78.8 (155.5)
Amyl nitrate (N) 0 37 10 2
Times in lifetime – 67.7 (255.8) 8.4 (6.8) 29.0 (26.9)
Ketamine (N)0 2 7 5 0
Grams in lifetime – 11.6 (18.8) 6.2 (6.9) –
Cocaine (N) 0 41 14 6
Grams in lifetime – 87.6 (165.8) 214 (687.5) 7.9 (9.3)
Opiates (N)0 1 4 8 0
Grams in lifetime – 9.2 (24.2) 76.8 (85.0) –
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As expected, subjects tolerated more uncertainty [a lower P
(Correct)] in the Reward Conflict condition than the Fixed
Reward condition, thus demonstrating sensitivity to the task
contingencies (see Table 3). There was a significant main effect
of Group (F3,86 = 5.45, P = 0.002), and a significant
Group × Gender interaction (F3,86 = 4.53, P = 0.005). The
other terms did not attain significance (all F < 1), and notably,
the Group × Condition interaction was not significant
(F3,86 = 0.621, P = 0.603) suggesting comparable sensitivity to
the change in conditions across groups. Post hoc group com-
parisons (Tukey’s) collapsed across Condition showed that the
cannabis users opened significantly fewer boxes compared with
the Ex-ecstasy group (P = 0.013), and differed at trend from
the Current ecstasy users (P = 0.076) and the drug-naïve con-
trols (P = 0.078). There were no differences between the ecstasy
groups and drug-naïve controls (see Figure 1). An a priori
planned contrast confirmed a significant difference between
the cannabis users and the drug-naive controls (t32 = 2.31,
P = 0.027) with a large effect size (Cohen’s d=0.81).
A simple main effects analysis of the Group × Gender inter-
action assessed the effect of Group in males and females sepa-
rately, collapsed across condition. The one-way ANOVA was
significant for male subjects (F3,52 = 6.77, P = 0.001), where
post hoc comparisons demonstrated significantly reduced infor-
mation sampling in male cannabis users compared to each of
the other three groups (Tukey’s: Ex-ecstasy users P < 0.001;
Current ecstasy users P = 0.035; drug-naïve controls
P = 0.038). The one-way ANOVA in female subjects was not
significant (F3,34 = 1.46, P = 0.242), but numerically, the
female cannabis group displayed the lowest information sam-
pling of the four groups. A post hoc analysis compared the
extent of cannabis usage (the main drug of abuse) across male
and female subjects in the polydrug group, and found similar
lifetime joints (t4.1 = 1.05, P = 0.350) and joints in the last
month (t4.5 = 1.1, P = 0.324) in the male and female partici-
pants, suggesting that the influence of gender on the IST per-
formance was not simply due to differences in drug usage.
Analysis of the number of boxes opened on the IST revealed
a qualitatively similar pattern of group differences to P(Cor-
rect) data, which is unsurprising given r > 0.9 correlations
between these variables (see task description in Methods).
There was a significant main effect of group in the mixed
model ANOVA (F3,90 = 5.83, P = 0.001) due to reduced infor-
mation sampling in the cannabis users compared with the
Ex-ecstasy group (Tukey’s P = 0.020) and the Current ecstasy
group (P = 0.059). There were greater group differences in the
male subjects (F3,52 = 7.07, P < 0.0001) than in the females
(F3,34 = 1.83, P = 0.161). Errors committed on the IST was
inversely correlated with boxes opened (r94 = –0.526,
P < 0.0001) and P(Correct) (r94 = –0.566, P < 0.0001), con-
firming a core principle of reflection impulsivity. However, the
mixed-model ANOVA of IST-errors found no significant main
effect of Group (F3,90 = 0.258, P = 0.855) or Group × Condi-
tion interaction (F3,90 = 1.80, P = 0.152). Finally, we examined
Table 3 Performance on the Information Sampling Task in the four groups [mean (SD)]
Drug-naive Ecstasy Ex-ecstasy Cannabis
Fixed reward
P(Correct) 0.85 (0.10) 0.84 (0.09) 0.86 (0.08) 0.78 (0.07)
Boxes 14.8 (4.6) 15.4 (4.4) 15.7 (4.1) 11.8 (3.8)
Errors 1.0 (1.1) 1.3 (1.1) 1.1 (1.0) 1.8 (1.2)
Reward conflict
P(Correct) 0.74 (0.06) 0.73 (0.06) 0.77 (0.07) 0.70 (0.07)
Boxes 8.9 (2.5) 9.3 (3.4) 11.2 (3.6) 8.2 (3.8)
Errors 2.5 (1.2) 2.3 (1.3) 2.2 (1.4) 2.1 (1.2)
Figure 1 Performance on the Information Sampling Test in the Current
and Ex-ecstasy users, cannabis users and drug-naïve controls, in terms of
the probability of making a correct response at the time of decision
[P(Correct)]. These data are collapsed across the two conditions of
the task (Fixed Reward and Reward Conflict) given the absence of a
significant group × condition interaction term. Error bars display standard
error of the mean. The asterisk signifies P < 0.05 in the comparison
against drug-naïve controls.
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scales of the Eysenck IVE, and IST performance [P(Correct)
collapsed across condition]. There was no significant associa-
tion in the overall group (Impulsivity: r94 = 0.003, P = 0.974;
Venturesomeness r94 = 0.043, P = 0.678) or in any of the four
groups (r = −0.33 to +0.19).
Discussion
The present study used a recently developed IST to measure
reflection impulsivity in current and former ecstasy users,
cannabis users and drug-naïve controls. In the Fixed Reward
condition (where there was no penalty for sampling further
information), the drug-naïve control group sampled informa-
tion to a point of 85% certainty (95% confidence intervals:
80–89%), similar to healthy performance in our previous
study (Clark, et al., 2006). Moreover, the number of boxes
opened and the level of certainty tolerated during decision-
making were both inversely correlated with incorrect judg-
ments in the overall sample (n = 94). This demonstrates the
central feature of a test of reflection impulsivity: the extent of
information sampling is predictive of eventual decision accu-
racy (Evenden, 1999a).
Regular cannabis users sampled significantly fewer boxes on
the IST and tolerated more uncertainty in making the correct
decision, compared with the other groups. This difference was
statistically significant in a planned comparison against the
drug-naïve control group, and the cannabis users sampled sig-
nificantly less information than the Ex-ecstasy group in the
more conservative Tukey’s post hoc group comparisons. The
cannabis users altered their information sampling behaviour
to a similar degree between the Fixed Reward and Reward
Decrement conditions, compared with the other groups (i.e.
the nonsignificant Group × Condition interaction term). This
indicates comparable sensitivity to the change in reward con-
tingencies, and suggests that the reduced information sampling
behaviour was not simply attributable to a lack of motivation
in the cannabis group. These data are also consistent with a
report of risky decision-making (on the Iowa Gambling Task)
in regular marijuana users (Whitlow, et al., 2004). Decision-
making impairments on complex tests like the Iowa Gambling
Task may putatively arise from a failure of pre-decisional
information sampling or evaluation. Our findings extend our
earlier observation of reduced information sampling in current
and former users of amphetamines or opiates, who met DSM-
IV criteria for dependence (Clark, et al., 2006). Given the pres-
ence of this effect across multiple substances of abuse with
distinct pharmacological targets (amphetamines, opiates, can-
nabis), we suggest that impaired reflection impulsivity may
represent a cognitive style associated with the pre-existing vul-
nerability to recreational drug use and later dependence,
consistent with data from high-risk prospective studies (Nigg,
et al., 2006; Tarter, et al., 2004).
We were unable to detect any significant group differences
on the IST between the ecstasy-using groups and the drug-
naïve controls. Several other studies have failed to substantiate
the link between ecstasy use and other aspects of impulsivity,
including the Stroop and Go/No Go tests (Dafters, 2006; Fox,
et al., 2002; Gouzoulis-Mayfrank, et al., 2003). However, our
findings fail to replicate several studies that have demonstrated
impulsivity in regular ecstasy users on another widely used test
of reflection, the MFFT (Morgan, 1998; Morgan, et al., 2002;
Morgan, et al., 2006; Quednow, et al., 2007). The ecstasy users
in the present study reported moderate use of other illicit sub-
stances, including similar cannabis usage to the cannabis
group. The two ecstasy groups were also more likely than the
cannabis group to have used a range of other substances,
including amphetamine, cocaine and opiates. Consequently, if
reduced reflection is a pre-existing cognitive style associated
with general recreational drug use, we would expect this effect
to have also been present in the two ecstasy groups. Lack of
statistical power seems unlikely to explain the negative result,
as the ecstasy groups actually sampled more information (in
terms of boxes opened), on average, than the drug-naïve con-
trols. In addition, the group size of 46 current ecstasy users is
reasonably large for studies of this kind, and the level of
ecstasy consumption was considerable (e.g. lifetime usage
means of 609 and 1001 in the Current and Ex-ecstasy groups
respectively), compared with the wider neuropsychological lit-
erature [e.g. 458 tablets in Quednow, et al. (2007)].
There are several possible explanations for the discrepancy
with the studies by Morgan, et al. (1998, 2002, 2006), and
Quednow, et al. (2007). One consideration is the duration of
abstinence from ecstasy, which was relatively long in the pres-
ent study (> 3 weeks) but much shorter in the positive studies,
ranging from 3 days (mean 17 days; Quednow, et al., 2007) to
5 days (Morgan, et al., 2005). Studies in experimental animals
reveal recoverable reductions in serotonin function 1–2 weeks
after dosing that do not indicate neurotoxicity (Gouzoulis-
Mayfrank & Daumann 2006). In addition, studies of other
drugs indicate that short-term withdrawal may exacerbate
behavioural impulsivity (see below). Lyvers and Hasking
(2004) recommended a 1-month abstinence window for neuro-
psychological studies. Hence, the positive MFFT results by
Morgan, et al. and Quednow, et al. could be caused by semi-
acute effects of serotonin depletion upon task performance.
We have shown previously that IST performance is related
to MFFT performance in healthy volunteers: fast, inaccurate
responders on the MFFT opened significantly fewer boxes on
the IST than slow, accurate responders (Clark, et al., 2003).
However, the MFFT involves a number of extraneous addi-
tional processes, including visual search, visual working mem-
ory and strategy implementation, which may be independently
impaired in regular ecstasy users (Fox, et al., 2002; Halpern,
et al., 2004; Wareing, et al., 2005). The design of the IST
explicitly aimed to minimize these extraneous demands. In the
MFFT study by Morgan (1998), there was a group difference
in MFFT accuracy but not latency, which may be plausibly
explained as a more general impairment. Other studies, how-
ever, reported significant differences in both speed and
Reflection impulsivity in cannabis and ecstasy users 19accuracy (Morgan, et al., 2006; Morgan, et al., 2002), which is
likely to indicate impulsivity.
Additional factors may mediate the deficits in laboratory
impulsivity in ecstasy users, and contribute to variability across
studies. Gender may be one such variable: in the present study,
the reduced information sampling in the cannabis group was
mainly attributable to the male subjects, and other studies
also described greater neuropsychological impairments in
male drug users than in female drug users (Ersche, et al.,
2006; Stout, et al., 2005), including ecstasy users (von Geusau,
et al., 2004). In addition to gender, studies of other groups of
drug-users with the delay discounting paradigm have indicated
greater impulsivity in current users compared with ex-users
(Bickel, et al., 1999; Petry, 2001). Two distinct mechanisms
may contribute to this effect: withdrawal and/or craving may
exacerbate impulsivity in current users (Field, et al., 2006;
Giordano, et al., 2002), but also, less impulsive drug users
may be more capable of achieving successful abstinence
(Bickel, et al., 1999). In the present data, there was no evidence
of the latter effect, as the Current and Ex-ecstasy users scored
similarly on the IVE and IST measures. It is possible that the
periods of abstinence from ecstasy in the Current (>3 weeks)
and Ex (>1 year) ecstasy groups had attenuated impulsivity
compared with the cannabis group, although against this expla-
nation, the ecstasy groups did report moderate recent usage of
other substances, including similar cannabis usage to the can-
nabis group in the past month.
Whilst we found no evidence of laboratory impulsivity on
the IST in the ecstasy group, self-reported impulsivity on the
Eysenck IVE questionnaire was significantly elevated in the
current and former ecstasy users. Questionnaire impulsivity
should indicate trait dispositions that are present prior to the
initiation of drug use; for example, de Win, et al. (2006)
showed no change on the Barratt Impulsiveness Scale before
and after initiation of ecstasy use in a prospective cohort. Pre-
vious studies suggest large variability in trait impulsivity in
ecstasy users, with a number of studies reporting elevations
(Butler and Montgomery, 2004; Morgan, 1998; Parrott, et al.,
2000), but other studies finding no differences (Travers and
Lyvers, 2005) and one study even finding a significant reduc-
tion (McCann, et al., 1994). In our data, there was no associa-
tion between the IVE score and performance on the IST. These
data highlight the multi-factorial nature of impulsivity, and are
in keeping with a number of other reports showing limited
associations between state (laboratory) and trait (question-
naire) measures of impulsivity (Dom, et al., 2007; Lijffijt,
et al., 2004; Reynolds, et al., 2006). Questionnaire ratings indi-
cate general behavioural tendencies across a variety of situa-
tions, and rely on a subjective perception of one’s behaviour.
In contrast, laboratory tasks provide an objective measure of a
specific facet of impulsivity at a single point in time. Weak cor-
relations between these two sets of variables may be a realistic
expectation. Similarly, our findings do not refute the possibility
that other domains of laboratory impulsivity (e.g. delay dis-
counting, response inhibition) may be impaired in ecstasy
groups. As discussed above, there are inconsistent findings
using tasks of response inhibition in ecstasy users (Dafters,
2006; Fox, et al., 2002; Gouzoulis-Mayfrank, et al., 2003),
and to our knowledge, no studies have yet explored delay-
discounting in regular ecstasy users.
Some further limitations of the present study should be
noted. Whilst the number of current ecstasy users was large,
the group sizes for the former ecstasy users and the cannabis
users were considerably smaller. In particular, the analyses
split by gender should be treated as preliminary due to the
reduced power, and need to be confirmed in a larger sample.
In addition, the two groups of ecstasy users showed a high
degree of polydrug use, although this arguably renders their
intact IST performance even more surprising.
In conclusion, these data support the position of reflection
impulsivity as a relevant cognitive dimension in regular drug
users, by demonstrating reduced information sampling in a
group of regular cannabis users. Reduced reflection is likely to
have a detrimental impact on wider-scale decision-making capa-
bilities, with potential relevance for treatment engagement and
the ability to maintain long-term abstinence. Unexpectedly, the
present study found no differences in reflection in current or for-
mer ecstasy users, despite evidence of trait impulsivity in these
subjects. These data appear to challenge a simplistic pathway
from ecstasy consumption to elevated impulsivity via serotonin
neurotoxicity.
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